Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review

PloS One
Sophia B GeorghiouTimothy C Rodwell

Abstract

Rapid molecular diagnostics for detecting multidrug-resistant and extensively drug-resistant tuberculosis (M/XDR-TB) primarily identify mutations in Mycobacterium tuberculosis (Mtb) genes associated with drug resistance. Their accuracy, however, is dependent largely on the strength of the association between a specific mutation and the phenotypic resistance of the isolate with that mutation, which is not always 100%. While this relationship is well established and reliable for first-line anti-TB drugs, rifampin and isoniazid, it is less well-studied and understood for second-line, injectable drugs, amikacin (AMK), kanamycin (KAN) and capreomycin (CAP). We conducted a systematic review of all published studies evaluating Mtb mutations associated with resistance to AMK, KAN, CAP in order to characterize the diversity and frequency of mutations as well as describe the strength of the association between specific mutations and phenotypic resistance in global populations. Our objective was to determine the potential utility and reliability of these mutations as diagnostic markers for detecting AMK, KAN and CAP resistance. Mutation data was reviewed for 1,585 unique clinical isolates from four continents and over 18 countries. Mutati...Continue Reading

References

Jan 1, 1970·Antibiotica Et Chemotherapia. Fortschritte. Advances. Progrès·L Trnka, D W Smith
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·N HonoréS T Cole
Mar 25, 1998·Journal of Medical Microbiology·F A Drobniewski, S M Wilson
May 21, 1998·Antimicrobial Agents and Chemotherapy·G J AlangadenS A Lerner
Jul 3, 1998·Journal of Clinical Microbiology·S A WattersonF A Drobniewski
Feb 7, 2001·Journal of Clinical Microbiology·M M HannanJ T Crawford
Sep 15, 2001·Antimicrobial Agents and Chemotherapy·B SpringerP Sander
Oct 9, 2002·Microbiology·Jean-Christophe CamusStewart T Cole
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Srinivas V RamaswamyEdward A Graviss
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Annika KrüünerSven Hoffner
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Courtney E MausThomas M Shinnick
Feb 11, 2005·Chemical Reviews·Sophie Magnet, John S Blanchard
Apr 13, 2005·Journal of Microbiological Methods·Daniela IsolaUNKNOWN LONG-DRUG study group
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Courtney E MausThomas M Shinnick
Jun 8, 2006·Journal of Clinical Microbiology·Pontus JureenSven E Hoffner
Feb 16, 2007·The New England Journal of Medicine·Mario C Raviglione, Ian M Smith
Oct 31, 2007·Journal of Molecular Biology·Divya SharmaRachel Green
Nov 6, 2007·Journal of Clinical Microbiology·Paolo MiottoGiovanni Battista Migliori
Oct 23, 2008·The Journal of Antimicrobial Chemotherapy·Joanna EvansHeidi Segal
Nov 14, 2008·Archivos de bronconeumología·Domingo J PalmeroJosé A Caminero Luna
Dec 25, 2008·BMC Microbiology·Karthik Raman, Nagasuma Chandra
Oct 23, 2009·Journal of Clinical Microbiology·Lulette Tricia C BravoNabin K Shrestha

❮ Previous
Next ❯

Citations

Jul 19, 2013·Future Medicinal Chemistry·Kristin J Labby, Sylvie Garneau-Tsodikova
Jun 8, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Z ZhangY Zhao
Dec 11, 2014·The Journal of Antimicrobial Chemotherapy·Alexander C OuthredVitali Sintchenko
May 28, 2013·BMC Infectious Diseases·Danila V ZimenkovDmitry A Gryadunov
Dec 13, 2012·The Journal of Antimicrobial Chemotherapy·Jacob L HoughtonSylvie Garneau-Tsodikova
Jan 19, 2013·World Journal of Microbiology & Biotechnology·Hum Nath JnawaliYoung Kil Park
Jun 12, 2013·Expert Opinion on Pharmacotherapy·Panagiotis Poulikakos, Matthew E Falagas
Apr 10, 2015·Pathogens·Charlotte MignonBettina Werle
Oct 9, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Betzaida Cuevas-CórdobaRoberto Zenteno-Cuevas
May 27, 2014·Clinics in Laboratory Medicine·Shou-Yean Grace Lin, Edward P Desmond
Nov 13, 2013·Journal of Infection and Public Health·Suhail Ahmad, Eiman Mokaddas
Feb 16, 2016·MedChemComm·Sylvie Garneau-Tsodikova, Kristin J Labby
Jun 29, 2015·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Zofia BakułaTomasz Jagielski
Feb 27, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Willy SsengoobaBouke C de Jong
Aug 11, 2015·Diagnostic Microbiology and Infectious Disease·Alicia LacomaJose Dominguez
Aug 9, 2015·Diagnostic Microbiology and Infectious Disease·Li-Li ZhaoKang-Lin Wan
Jun 12, 2015·ACS Infectious Diseases·Keith D GreenSylvie Garneau-Tsodikova
May 6, 2015·The Journal of Infection·B Molina-MoyaJ Dominguez
Mar 15, 2015·The Journal of Infectious Diseases·Hugh SalamonDavid L Dolinger
Sep 1, 2016·BMC Infectious Diseases·Sophia B GeorghiouTimothy C Rodwell
Jan 31, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Young Seok LeeTae Sun Shim
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Devan JaganathPeter R Donald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.